| Literature DB >> 26325217 |
Reid A Roberts1,2, Timothy K Eitas1, James D Byrne3,2, Brandon M Johnson1, Patrick J Short4, Karen P McKinnon1, Shannon Reisdorf1, J Christopher Luft3, Joseph M DeSimone3,4,5,6,7, Jenny P Ting1,8,9,10.
Abstract
The possibility of engineering the immune system in a targeted fashion using biomaterials such as nanoparticles has made considerable headway in recent years. However, little is known as to how modulating the spatial presentation of a ligand augments downstream immune responses. In this report we show that geometric manipulation of phosphatidylserine (PS) through fabrication on rod-shaped PLGA nanoparticles robustly dampens inflammatory responses from innate immune cells while promoting T regulatory cell abundance by impeding effector T cell expansion. This response depends on the geometry of PS presentation as both PS liposomes and 1 micron cylindrical PS-PLGA particles are less potent signal inducers than 80 × 320 nm rod-shaped PS-PLGA particles for an equivalent dose of PS. We show that this immune tolerizing effect can be co-opted for therapeutic benefit in a mouse model of multiple sclerosis and an assay of organ rejection using a mixed lymphocyte reaction with primary human immune cells. These data provide evidence that geometric manipulation of a ligand via biomaterials may enable more efficient and tunable programming of cellular signaling networks for therapeutic benefit in a variety of disease states, including autoimmunity and organ rejection, and thus should be an active area of further research.Entities:
Keywords: Autoimmunity; Immunoengineering; Immunomodulation; Nanoparticles; PLGA; PRINT; Phosphatidylserine; Tolerance; Transplantation
Mesh:
Substances:
Year: 2015 PMID: 26325217 PMCID: PMC4852957 DOI: 10.1016/j.biomaterials.2015.08.040
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479